Skip to Content

A team of researchers led by Jon S Matsumura, MD, Division Chief of Vascular Surgery, found the clinical trial PROTECT (Carotid Artery Stenting with Distal Embolic Protection with Improved System) had the lowest rate of complications ever in patients considered high risk for carotid endarterectomy (CEA)—the gold standard for opening a blocked carotid artery. Carotid artery stenosis, or the narrowing of blood vessels in the neck, is one of the leading causes of strokes in the United States. The findings, with Dr. Matsumura as the lead author, are published in the most recent edition of Journal of Vascular Surgery.

“Recent improvements in devices designed specifically for carotid artery stenting have resulted in safer procedures and better clinical outcomes,” says Matsumura. “These technological advances, combined with a stronger understanding of patient risk factors, have also improved our ability to select which patients are best suited for the less invasive procedure.”

Click below to read more on this exciting new study.
UW School of Medicine and Public Health
ScienceCodex
DailyRX

webmaster@surgery.wisc.edu Copyright © 2016 The Board of Regents of the University of Wisconsin System